La vendita allo scoperto per Vita Coco dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Vita Coco. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Vita Coco (NASDAQ:COCO) Azioni, Report sulle vendite allo scoperto

Vita Coco

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

The Vita Coco Company, Inc. - Common Stock

The Vita Coco Co Inc

Cocos-BCX

COCONALA INC by COCONALA INC.

<p>Wells Fargo  analyst Chris Carey   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Overweight and raises the price target from $39 to $43.</p>


News

Price Target

Analyst Ratings

COCO

Wells Fargo Maintains Overweight on Vita Coco, Raises Price Target to $43

<p>Evercore ISI Group  analyst Robert Ottenstein   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Outperform and raises the price target from $35 to $38.</p>


Evercore ISI Group Maintains Outperform on Vita Coco, Raises Price Target to $38

WIIM

Vita Coco shares are trading higher after the company reported better-than-expected Q1 financial results.

<p>Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) affirms FY2025 sales outlook from $555.00 million-$570.00 million to $555.00 million-$570.00 million vs $568.75 million estimate.</p>


Guidance

Vita Coco Affirms FY2025 Sales Guidance of $555.00M-$570.00M vs $568.75M Est

<p>Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.20 by 55 percent. This is a 29.17 percent increase over earnings of $0.24 per share from the same period last year.  The company reported quarterly sales of $130.92 million which beat the analyst consensus estimate of $125.49 million by 4.33 percent.  This is a 17.21 percent increase over sales of $111.70 million the same period last year.</p>


Earnings

Earnings Beats

Vita Coco Q1 GAAP EPS $0.31 Beats $0.20 Estimate, Sales $130.92M Beat $125.49M Estimate

AEIS

ALGN

ALKT

AMCR

ANSS

ARAY

ATNI

AWRE

BLCO

BLFY

BLKB

BXMT

CACC

CAKE

CDNA

CFLT

CGNX

CHEF

CHRW

CLMB

CMPR

CNMD

CNXN

COKE

CPSH

CSLR

CSTM

CTOS

CTSH

CVEO

CWAN

CWEN

DFIN

EBAY

ENVX

EQIX

EQNR

ETSY

EXTR

FCPT

FFWM

FINW

FMBH

FORM

FTAI

GEHC

GKOS

GNRC

GRBK

GRMN

GTES

Earnings Scheduled For April 30, 2025

<p>Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) will release its quarterly earnings report on Wednesday, 2025-04-30. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Vita Coco to report an <strong>earnings per share</strong> (EPS) of $0.23.</p>
<p>The announcement from Vita Coco is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.02, which was followed by a 4.42% drop in the share price the next day.</p>
<p>Here's a look at Vita Coco's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.26</td>
<td>0.29</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.06</td>
<td>0.32</td>
<td>0.32</td>
<td>0.24</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>0.0%</td>
<td>3.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745949703_0.png" alt="eps graph" /></p>
<h3>Performance of Vita Coco Shares</h3>
<p>Shares of Vita Coco were trading at $30.12 as of April 28. Over the last 52-week period, shares are up 19.3%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Vita Coco</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Vita Coco.</p>
<p>Analysts have given Vita Coco a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $36.33, indicating a potential 20.62% upside.</p>
<h3>Comparing Ratings with Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of  and Vita Coco, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for  and Vita Coco, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vita Coco</td>
<td>Buy</td>
<td>19.92%</td>
<td>$41.31M</td>
<td>1.32%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Vita Coco ranks at the top for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, it is at the bottom compared to its peers.</p>
<h3>Delving into Vita Coco's Background</h3>
<p>The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever &amp; Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.</p>
<h3>Breaking Down Vita Coco's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Vita Coco's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>19.92%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>2.65%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>1.32%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.94%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Vita Coco's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.0</strong>.</p>
<p><a href="https://www.benzinga.com/quote/COCO/earnings"><strong>To track all earnings releases for Vita Coco visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What's Next: Vita Coco's Earnings Preview

ABEV

ANDE

BRBR

BRFS

CART

CASY

CELH

CENT

CENTA

COST

COTY

FIZZ

Fomento Economico Mexicano S.A.B. De C.V.

FRPT

HFFG

HNST

IPAR

ISPR

MDLZ

MGPI

MNST

PFGC

PSMT

SNYR

TBBB

UNFI

UPXI

USFD

USNA

WALD

WEST

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

<p>Stephens &amp; Co.  analyst Jim Salera   reiterates Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Equal-Weight and maintains $32 price target.</p>


Reiteration

Stephens & Co. Reiterates Equal-Weight on Vita Coco, Maintains $32 Price Target

<p>The Vita Coco Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) ("Vita Coco" or the "Company"), a leading high-growth platform of better-for-you beverage brands, today provided the following response to the recent short seller report issued by NINGI Research, who subsequently disclosed a short position in The Vita Coco Company stock.</p>
<p>After reviewing the claims outlined in NINGI Research's report, the Company has found that the report contains numerous inaccuracies and mischaracterizations. Contrary to this report, the Company has consistently and transparently addressed the matters discussed in the report through appropriate public disclosures.</p>
<p>The Company stated on the Fourth Quarter and Fiscal-Year 2024 Earnings Call held on Wednesday, February 26, 2025:</p>
<p>"As we've previously highlighted, last year, we experienced significant inventory constraints which led to unacceptable private label service levels that were below our standards. As a result of these challenges, we currently expect to lose some regions with certain private label retailers during 2025. Assuming this occurs, this will initially appear on our second quarter shipments with deeper impact in subsequent quarters. These assumptions are built into our current forecast for full year net sales<i>.</i>"</p>
<p>There have been no material changes since this statement was made. The Vita Coco Company is confident in its governance, financial reporting and business practices, and reaffirms the disclosures and guidance that it provided during it most recent earnings release.</p>


The Vita Coco Company Releases Response To Recent Short Seller Report Issued By Ningi Research

Vita Coco shares are trading lower following a bearish report from NINGI Research.

<p><a href="https://ningiresearch.com/2025/03/26/vita-coco-nasdaq-coco-structural-issues-amid-stalling-sales-and-costco-contract-loss/" title="https://ningiresearch.com/2025/03/26/vita-coco-nasdaq-coco-structural-issues-amid-stalling-sales-and-costco-contract-loss/">https://ningiresearch.com/2025/03/26/vita-coco-nasdaq-coco-structural-issues-amid-stalling-sales-and-costco-contract-loss/</a></p>


Short Sellers

Trading Ideas

Watching The Vita Coco Company; NINGI Research Issues Report On Co Titled "Vita Coco – Structural Issues Amid Stalling Sales And Costco Contract Loss"

<p>Wells Fargo  analyst Chris Carey   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Overweight and lowers the price target from $40 to $39.</p>


Wells Fargo Maintains Overweight on Vita Coco, Lowers Price Target to $39

<p>Goldman Sachs  analyst Bonnie Herzog   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Buy and raises the price target from $34 to $38.</p>


Goldman Sachs Maintains Buy on Vita Coco, Raises Price Target to $38

The Vita Coco Company shares are trading lower after the company reported worse-than-expected Q4 EPS results.

Vita Coco Company Sees 2025 Net Sales To Be Between $555M-$570M Vs. $569.11M Estimate

<p>Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. This is a 45.45 percent decrease over earnings of $0.11 per share from the same period last year.  The company reported quarterly sales of $127.29 million which beat the analyst consensus estimate of $120.91 million by 5.28 percent.  This is a 19.92 percent increase over sales of $106.14 million the same period last year.</p>


Earnings Misses

Vita Coco Q4 EPS $0.06 Misses $0.08 Estimate, Sales $127.29M Beat $120.91M Estimate

AAOI

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CERT

CLDT

CLPT

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

HCAT

IBTA

IMCR

Earnings Scheduled For February 26, 2025

<p>Wells Fargo  analyst Chris Carey   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Overweight and raises the price target from $33 to $40.</p>


Wells Fargo Maintains Overweight on Vita Coco, Raises Price Target to $40

<p>B of A Securities  analyst Bryan Spillane   maintains Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) with a Neutral and raises the price target from $30 to $38.</p>


B of A Securities Maintains Neutral on Vita Coco, Raises Price Target to $38

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of The Vita Coco Company, Inc. - COCO

The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

The Vita Coco Company, Inc. Releases 2024 Impact Report

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of The Vita Coco Company, Inc. - COCO

Bragar Eagel & Squire, P.C. Is Investigating XP, Vita Coco, KinderCare, and SelectQuote and Encourages Investors to Contact the Firm

Small Cap

Opinion

The $600B Beverage Shift: Why Function Is Outpacing Flavor

The Vita Coco Company to Participate in the William Blair 45th Annual Growth Stock Conference

Comments

Vita Coco

Vendite allo scoperto

Vita Coco (NASDAQ:COCO) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO